[PDF] Top 20 Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
Has 10000 "Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines." found on our website. Below are the top 20 most common "Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.".
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
... Deregulation of Hh signaling contributes to tumorigenesis or accelerates tumor growth in an Hh ligand-independent or -dependent ...manner[43]. In most basal cell ... See full document
16
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
... combination of LMR and MBR could predict prognosis in EGFR -mutant NSCLC patients receiving first-line ...incidence of brain and distant ...role in the anticancer response[11], and ... See full document
13
Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
... trials of the anti-insulin-like growth factor-1 receptor (IGF1R) antibody figitumumab in non-small cell lung cancer (NSCLC) patients have been ... See full document
9
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.
... with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop acquired resistance to EGFR tyrosine ... See full document
13
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
... Lung cancer leads cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC), the most prevalent subtype of this recalcitrant cancer, is ... See full document
11
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
... Epidermal growth factor receptor (EGFR), member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating ... See full document
22
Estrogenic Regulation of the SCF/c-KIT System in Prostate Cells: a Relationship with Prostate Cancer?
... µm) of rat prostate were deparaffinized in xylene (2x5 minutes), rehydrated in ethanol/water graded solutions (2x3 minutes in 100 % ethanol, 3 minutes in 95 % ethanol and 3 minutes ... See full document
110
mTOR pathway in BRAF mutated papillary thyroid carcinoma.
... (FFPE)] of 133 patients were collected from the files of the Hos- pital Sa˜o Joa˜o/Medical Faculty of the University of Porto, Por- tugal; the Institute of Molecular Pathology and ... See full document
11
Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize
... only cancer vaccine approved by the FDA. This vaccine consists of autologous peripheral blood mononuclear cells (PBMC) obtained by leukapheresis and cultured with the fusion protein that combines ... See full document
7
Arq Bras Endocrinol Metab vol.51 número4
... Translocation of Ras to the cytoplasmatic mem- brane is an important step in its ...farnesylation of Ras is the first oblig- atory step in a series of post-translational ... See full document
13
Análise da expressão gênica diferencial das glândulas de veneno de Bothrops jararaca...
... regulation of keratinocyte differentiation; P:peripheral nervous system neuron axonogenesis; P:somatic stem cell division; P:secretory columnal luminar epithelial cell differentiation involved ... See full document
308
Study on invadopodia formation for lung carcinoma invasion with a microfluidic 3D culture device.
... applications in biology, biochemistry, biotechnology, medicine, and in clinical studies ...number of studies for various cell-functional measurements based on this microfluidic system have ... See full document
7
Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.
... ng of total RNA from each sample was used to label the cRNA probes by Ambion Illumina TotalPrep RNA Amplification kit (cat no: ...ug of the amplified and labeled cRNA probes was hybridized to ... See full document
15
Recent Updates on the Management of Medullary Thyroid Carcinoma
... trials of vandetanib and cabozantinib versus placebo in patients with advanced ...VEGFR-3, epidermal growth factor receptor [23,24]. In a randomized, double-blind, ... See full document
8
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
... means of absolute frequencies and ...used to check for normality. Differences in median mRNA expression levels between histological types were assessed by the U Mann-Whitney ...used to measure ... See full document
7
Chemokines in Homeostasis and Cancers
... a small group of related chemoattractant peptides that play an essential role in the development and homeostatic maintenance of the immune ...recruitment of cells needed for the ... See full document
12
MicroRNAs in lung cancer
... ‘knockdown’ of miR-153 resulted in downregulation or increased expression of SNAI1 (Snail Family Zinc Finger 1) and ZEB2 (Zinc Finger E-Box Binding Homeobox 2) protein levels, ...repression of ... See full document
7
Flavonoid Composition and Antitumor Activity of Bee Bread Collected in Northeast Portugal
... mixture of plant pollen, honey, and bee saliva that worker bees use as food for larvae, and for young bees to produce royal ...jelly. In the present study, five BB samples, collected from Apis ... See full document
12
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
... found to be only useful in patients with an increased pre-treatment level ...levels of lactate dehydrogenase and chromogranin A did not correlate with treatment response ...measurement of ... See full document
10
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... component of inflammation, is the first type of immune cell that responds to the site of infection and attack invaders ...found in tumors are more likely to contribute ... See full document
14
temas relacionados